Secondary Analyses
Below is a summary of completed, in progress, and planned secondary analyses for the VICTORIA study.
| Analyses | Status (Completed, In Progress, Planned) | Related Links |
|---|---|---|
| Contextual with other trials | Completed | Circulation publication |
| Impact of natriuretic peptides on result and their evolution | Completed | JACC FF publication HFA 20 presentation |
| Index admission groups | Completed | JAMA Cardiol. publication |
| Prognostic model | In Progress | HFA 21 Presentation |
| Standard of Care | In Progress | HFSA 2020 presentation |
| Anemia | In Progress | |
| Baseline changes in renal function | In Progress | Eur J Heart Fail. publication |
| Sequential natriuretic peptides and outcomes | In Progress | HFA 21 Presentation |
| Atrial fibrillation | In Progress | HFA 21 Presentation |
| Safety/hypotension/syncope/ BP response | In Progress | HFA 21 Presentation |
| CAD/non CAD | In Progress | ACC 21 presentation |
| Sacubitril/valsartan baseline/ drop ins | In Progress | |
| Recurrent events | In Progress | |
| ECHO 1 paired data and Rx effect | In Progress | HFA 20 presentation |
| Genomics | In Progress | |
| Biomarkers | In Progress | ACC 21 presentation |
| Health economics | In Progress | |
| NA registry | In Progress | HFSA 20 Presentation |
| NA Registry – GDMT | In Progress | HFSA 20 Presentation |
| PK/PD and PK adherence | In Progress | |
| QoL as an outcome/predictor | In Progress | |
| LVEF stratification | In Progress | |
| Sex/Age | In Progress | |
| Geographic variation | In Progress | |
| Expanded endpoints | In Progress | |
| Risk Scores across spectrum MAGGIC, SHFM, others | Planned | |
| ECHO 2 remodelling | Planned |
